Which is better, HIVE or MSCI?

On the Buffett-Fit framework, MSCI Inc. (MSCI) currently grades higher than HIVE — 80/100 (A grade) vs 36/100 (D). That said, "better" depends on which framework you trust — HIVE wins on none; MSCI wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy HIVE or MSCI?

This page is an educational comparison, not investment advice. Both HIVE and MSCI are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is HIVE better than MSCI for value investing?

On the Buffett-style value-investing framework, MSCI currently grades higher — 80/100 vs 36/100, a 44-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between HIVE and MSCI on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). HIVE currently scores 36/100 (D grade); MSCI scores 80/100 (A grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, HIVE or MSCI?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. HIVE and MSCI are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, HIVE or MSCI?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are HIVE and MSCI both Financial Services stocks?

Yes — both HIVE Digital Technologies Ltd. (HIVE) and MSCI Inc. (MSCI) operate in the Financial Services sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this HIVE vs MSCI comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

HIVE Digital Technologies

MSCI

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

HIVE

Market cap

$1.03B

Sector

Financials

MSCI

Market cap

$42.85B

Sector

Financials

Overall winner

MSCI MSCI

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	HIVE	MSCI	Winner
Warren Buffett	36D	80A	MSCI
Benjamin Graham	22F	71B	MSCI
Philip Fisher

Side-by-side metrics

Metric	HIVE	MSCI
Market cap	$1.03B	$42.85B
P/E (TTM)	-	31.2x
EV/EBIT	445.5x	27.5x
ROIC (TTM)	7.75%	38.53%
Gross margin	22.78%	82.86%
Net margin	-27.99%	40.74%
Revenue CAGR 5y	14.24%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

HIVE leads on

P/E (TTM)-vs 31.2x+130%
Revenue CAGR 5y14.24%vs 11.29%+21%

MSCI leads on

Net margin40.74%vs -27.99%+169%

More like HIVE

HIVE vs MA HIVE vs SLDE HIVE vs HLNE HIVE vs KNSL HIVE vs SPGI HIVE vs EVR

More like MSCI

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.